HIA
RCEL icon

Harbor Investment Advisory’s Avita Medical RCEL Stock Holding History

Harbor Investment Advisory’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-140
Closed -$3K – 1302
2020
Q4 		$3K Hold
140
– – ﹤0.01% 1069
2020
Q3 		$4K Hold
140
– – ﹤0.01% 973
2020
Q2 		$4K Hold
140
– – ﹤0.01% 900
2020
Q1 		$4K Sell
140
-3,210
-96% -$133K ﹤0.01% 883
2019
Q4 		$152K Buy
+3,350
New +$139K 0.04% 286

Other funds holding RCEL

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbor Investment Advisory's RCEL Position: Q1 2021 in Review

Harbor Investment Advisory sold out of Avita Medical (RCEL) in Q1 2021, closing a stake of 140 shares — an estimated $3K sold.

Harbor Investment Advisory first reported a position in RCEL in Q4 2019 and held it in 5 quarters. The position peaked at $152K in Q4 2019. 61 funds tracked by Wall St. Rank hold RCEL as of Q1 2021.

  • Harbor Investment Advisory reported no remaining Avita Medical position as of Q1 2021 after selling out during the quarter.
  • Harbor Investment Advisory sold 140 Avita Medical shares in Q1 2021, an estimated $3K.
  • Harbor Investment Advisory first reported a position in Avita Medical in Q4 2019 and held it in 5 quarters.
  • Harbor Investment Advisory's Avita Medical position peaked at $152K in Q4 2019.
  • 61 funds tracked by Wall St. Rank held Avita Medical as of Q1 2021.

Based on Harbor Investment Advisory's 13F filing for Q1 2021, filed 16 Apr 2021.